Gene Center Munich
print


Breadcrumb Navigation


Content

Theurich Lab - Publications

2020   |   2019   |   2018   |   2017   |   2016   |   2015   |   2014   |   2013   |   2012   |   2011   |  2009  and before

 

2020

Geschwollene Lymphknoten im Auge behalten! Onkologische Zufallsbefunde [Lymph node enlargement].
Rückel E, Theurich S.
MMW Fortschr Med. 2020 Apr;162(7):32-35. German. doi: 10.1007/s15006-020-0387-x. PMID: 32291664.

ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.
Redondo Monte E, Wilding A, Leubolt G, Kerbs P, Bagnoli JW, Hartmann L, Hiddemann W, Chen-Wichmann L, Krebs S, Blum H, Cusan M, Vick B, Jeremias I, Enard W, Theurich S, Wichmann C, Greif PA.
Oncogene. 2020 Apr;39(15):3195-3205. doi: 10.1038/s41388-020-1209-4. Epub 2020 Mar 2. PMID: 32115572; PMCID: PMC7142018.

Corrigendum: Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, Baues C.
Front Pharmacol. 2020 Jan 31;10:1615. doi: 10.3389/fphar.2019.01615. Erratum for: Front Pharmacol. 2019 May 14;10:511. PMID: 32082149; PMCID: PMC7006368.

Single-slice CT measurements allow for accurate assessment of sarcopenia and body composition.
Zopfs D, Theurich S, Große Hokamp N, Knuever J, Gerecht L, Borggrefe J, Schlaak M, Pinto Dos Santos D.
Eur Radiol. 2020 Mar;30(3):1701-1708. doi: 10.1007/s00330-019-06526-9. Epub 2019 Nov 27. PMID:
31776743.

Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy.
Fürstenau M, Hopfinger G, Robrecht S, Fink AM, Al-Sawaf O, Langerbeins P, Cramer P, Tresckow JV, Maurer C, Kutsch N, Hoechstetter M, Dreyling M, Lange E, Kneba M, Stilgenbauer S, Döhner H, Hensel M, Kiehl MG, Jaeger U, Wendtner CM, Goede V, Fischer K, von Bergwelt-Baildon M, Eichhorst B, Hallek M, Theurich S.
Leukemia. 2020 Apr;34(4):1177-1181. doi: 10.1038/s41375-019-0630-6. Epub 2019 Nov 14. PMID: 31728057.

to

2019

Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.
Piechotta V, Jakob T, Langer P, Monsef I, Scheid C, Estcourt LJ, Ocheni S, Theurich S, Kuhr K, Scheckel B, Adams A, Skoetz N.
Cochrane Database Syst Rev. 2019 Nov 25;2019(11):CD013487. doi: 10.1002/14651858.CD013487. PMID: 31765002; PMCID: PMC6876545.

Exosome-dependent immune surveillance at the metastatic niche requires BAG6 and CBP/p300-dependent acetylation of p53.
Schuldner M, Dörsam B, Shatnyeva O, Reiners KS, Kubarenko A, Hansen HP, Finkernagel F, Roth K, Theurich S, Nist A, Stiewe T, Paschen A, Knittel G, Reinhardt HC, Müller R, Hallek M, von Strandmann EP.
Theranostics. 2019 Aug 14;9(21):6047-6062. doi: 10.7150/thno.36378. PMID: 31534536; PMCID: PMC6735508.

Abscopal Effects in Radio-Immunotherapy-Response Analysis of Metastatic Cancer Patients With Progressive Disease Under Anti-PD-1 Immune Checkpoint Inhibition.
Trommer M, Yeo SY, Persigehl T, Bunck A, Grüll H, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Herter JM, Celik E, Marnitz S, Baues C.
Front Pharmacol. 2019 May 14;10:511. doi: 10.3389/fphar.2019.00511. Erratum in: Front Pharmacol. 2020 Jan 31;10:1615. PMID: 31156434; PMCID: PMC6530339.

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma.
Lechner A, Schlößer HA, Thelen M, Wennhold K, Rothschild SI, Gilles R, Quaas A, Siefer OG, Huebbers CU, Cukuroglu E, Göke J, Hillmer A, Gathof B, Meyer MF, Klussmann JP, Shimabukuro-Vornhagen A, Theurich S, Beutner D, von Bergwelt-Baildon M.
Oncoimmunology. 2019 Jan 10;8(3):1535293. doi: 10.1080/2162402X.2018.1535293. PMID: 30723574; PMCID: PMC6350680.

to

2018

Robotic Stereotactic Radiosurgery in Melanoma Patients with Brain Metastases under Simultaneous Anti-PD-1 Treatment.
Trommer-Nestler M, Marnitz S, Kocher M, Rueß D, Schlaak M, Theurich S, von Bergwelt-Baildon M, Morgenthaler J, Jablonska K, Celik E, Ruge MI, Baues C.
Int J Mol Sci. 2018 Sep 7;19(9):2653. doi: 10.3390/ijms19092653. PMID: 30205431; PMCID: PMC6164579.

Immuncheckpoint-Inhibitoren: Aktuelle Indikationen und mögliche zukünftige Konzepte [Immuncheckpoint Inhibitors: Current Indications and Possible Future Concepts].
Schlaak M, Baues C, Trommer-Nestler M, Berking C, Belka C, Theurich S.
Dtsch Med Wochenschr. 2018 Jul;143(14):1014-1021. German. doi: 10.1055/s-0043-125001. Epub 2018 Jul 13. PMID: 30005435.

Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment.
Wunderlich CM, Ackermann PJ, Ostermann AL, Adams-Quack P, Vogt MC, Tran ML, Nikolajev A, Waisman A, Garbers C, Theurich S, Mauer J, Hövelmeyer N, Wunderlich FT. 
Nat Commun. 2018 Apr 25;9(1):1646. doi: 10.1038/s41467-018-03773-0. PMID: 29695802; PMCID:
PMC5916940.

top

2017

Serotonin Shapes the Migratory Potential of NK Cells - An in vitro Approach.
Zimmer P, Bloch W, Kieven M, Lövenich L, Lehmann J, Holthaus M, Theurich S, Schenk A.
Int J Sports Med. 2017 Oct;38(11):857-863. doi: 10.1055/s-0043-113042. Epub 2017 Aug 7. PMID: 28783845.

Using Antigen- Specific B Cells to Combine Antibody and T Cell-Based Cancer Immunotherapy.Wennhold K, Thelen M, Schlößer HA, Haustein N, Reuter S, Garcia-Marquez M, Lechner A, Kobold S, Rataj F, Utermöhlen O, Chakupurakal G, Theurich S, Hallek M, Abken H, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M.
Cancer Immunol Res. 2017 Sep;5(9):730-743. doi: 10.1158/2326-6066.CIR-16-0236. Epub 2017 Aug 4. PMID: 28778961.

Should we be combining local tumor therapies with immunotherapies as standard?
Baues C, Schlaak M, von Bergwelt-Baildon M, Theurich S.
Future Oncol. 2017 Aug;13(18):1573-1575. doi: 10.2217/fon-2017-0150. Epub 2017 Aug 22. PMID: 28829189.

IL-6/Stat3-Dependent Induction of a Distinct, Obesity-Associated NK Cell Subpopulation Deteriorates Energy and Glucose Homeostasis.
Theurich S, Tsaousidou E, Hanssen R, Lempradl AM, Mauer J, Timper K, Schilbach K, Folz-Donahue K, Heilinger C, Sexl V, Pospisilik JA, Wunderlich FT, Brüning JC.
Cell Metab. 2017 Jul 5;26(1):171-184.e6. doi: 10.1016/j.cmet.2017.05.018. PMID: 28683285.

Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A, Schlößer H, Rothschild SI, Thelen M, Reuter S, Zentis P, Shimabukuro-Vornhagen A, Theurich S, Wennhold K, Garcia-Marquez M, Tharun L, Quaas A, Schauss A, Isensee J, Hucho T, Huebbers C, von Bergwelt-Baildon M, Beutner D.
Oncotarget. 2017 Jul 4;8(27):44418-44433. doi: 10.18632/oncotarget.17901. PMID: 28574843; PMCID: PMC5546490.

Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance.
Xu E, Pereira MMA, Karakasilioti I, Theurich S, Al-Maarri M, Rappl G, Waisman A, Wunderlich FT, Brüning JC.
Nat Commun. 2017 May 3;8:14803. doi: 10.1038/ncomms14803. PMID: 28466852; PMCID: PMC5418621.

CD40-activated B cells induce anti-tumor immunity in vivo.
Wennhold K, Weber TM, Klein-Gonzalez N, Thelen M, Garcia-Marquez M, Chakupurakal G, Fiedler A, Schlösser HA, Fischer R, Theurich S, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M. 
Oncotarget. 2017 Apr 25;8(17):27740-27753. doi: 10.18632/oncotarget.7720. PMID: 26934557; PMCID: PMC5438605.

Short review of potential synergies of immune checkpoint inhibition and radiotherapy with a focus on Hodgkin lymphoma: radio-immunotherapy opens new doors.
Baues C, Trommer-Nestler M, Jablonska K, Bröckelmann PJ, Schlaak M, von Bergwelt-Baildon M, Engert A, Semrau R, Marnitz S, Theurich S.
Immunotherapy. 2017 Mar;9(5):423-433. doi: 10.2217/imt-2017-0002. PMID: 28357914.

Innovative Treatment Concepts for Cutaneous T-Cell Lymphoma Based on Microenvironment Modulation. Leuchte K, Schlaak M, Stadler R, Theurich S, von Bergwelt-Baildon M.
Oncol Res Treat. 2017;40(5):262-269. doi: 10.1159/000472257. Epub 2017 Apr 20. PMID: 28423378.

top

2016

Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease.
Chakupurakal G, Garcia-Marquez MA, Shimabukuro-Vornhagen A, Kluth S, Schlosser H, Theurich S, Scheid C, Hallek M, Holtick U, von Bergwelt-Baildon M.
Eur J Haematol. 2017 Feb;98(2):128-133. doi: 10.1111/ejh.12810. Epub 2016 Nov 6. PMID: 27717015.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.
Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC. 
Cell. 2016 Aug 25;166(5):1338-1340. doi: 10.1016/j.cell.2016.08.010. Erratum for: Cell. 2016 May 5;165(4):882-95. PMID: 27565353.

Antigen-presenting human B cells are expanded in inflammatory conditions.
Shimabukuro-Vornhagen A, García-Márquez M, Fischer RN, Iltgen-Breburda J, Fiedler A, Wennhold K, Rappl G, Abken H, Lehmann C, Herling M, Wolf D, Fätkenheuer G, Rubbert-Roth A, Hallek M, Theurich S, von Bergwelt-Baildon M.
J Leukoc Biol. 2017 Feb;101(2):577-587. doi: 10.1189/jlb.5A0416-182R. Epub 2016 Aug 17. PMID: 27534894.

Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma.
Theurich S, Rothschild SI, Hoffmann M, Fabri M, Sommer A, Garcia-Marquez M, Thelen M, Schill C, Merki R, Schmid T, Koeberle D, Zippelius A, Baues C, Mauch C, Tigges C, Kreuter A, Borggrefe J, von Bergwelt-Baildon M, Schlaak M.
Cancer Immunol Res. 2016 Sep 2;4(9):744-54. doi: 10.1158/2326-6066.CIR-15-0156. Epub 2016 Jul 27. PMID: 27466265.

Myeloid-Cell-Derived VEGF Maintains Brain Glucose Uptake and Limits Cognitive Impairment in Obesity.
Jais A, Solas M, Backes H, Chaurasia B, Kleinridders A, Theurich S, Mauer J, Steculorum SM, Hampel B, Goldau J, Alber J, Förster CY, Eming SA, Schwaninger M, Ferrara N, Karsenty G, Brüning JC.
Cell. 2016 May 5;165(4):882-95. doi: 10.1016/j.cell.2016.03.033. Epub 2016 Apr 28. Erratum in: Cell. 2016 Aug 25;166(5):1338-1340. PMID: 27133169.

Physical exercise modulates the homeostasis of human regulatory T cells.
Weinhold M, Shimabukuro-Vornhagen A, Franke A, Theurich S, Wahl P, Hallek M, Schmidt A, Schinköthe T, Mester J, von Bergwelt-Baildon M, Bloch W.
J Allergy Clin Immunol. 2016 May;137(5):1607-1610.e8. doi: 10.1016/j.jaci.2015.10.035. Epub 2016 Jan 7. PMID: 26774657.

Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
Becker HJ, Kondo E, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon MS. 
Eur J Haematol. 2016 Aug;97(2):166-74. doi: 10.1111/ejh.12699. Epub 2015 Dec 10. PMID: 26561366.

to

2015

Immunological effects in patients with steroid-refractory graft-versus-host disease following treatment with basiliximab, a CD25 monoclonal antibody.
Chakupurakal G, García-Márquez MA, Shimabukuro-Vornhagen A, Theurich S, Holtick U, Hallek M, Scheid C, von Bergwelt-Baildon M.
Eur J Haematol. 2016 Aug;97(2):121-7. doi: 10.1111/ejh.12691. Epub 2015 Nov 16. PMID: 26492560.

Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.
Schlößer HA, Drebber U, Kloth M, Thelen M, Rothschild SI, Haase S, Garcia-Marquez M, Wennhold K, Berlth F, Urbanski A, Alakus H, Schauss A, Shimabukuro-Vornhagen A, Theurich S, Warnecke-Ebertz U, Stippel DL, Zippelius A, Büttner R, Hallek M, Hölscher AH, Zander T, Mönig SP, von Bergwelt-Baildon M. 
Oncoimmunology. 2015 Nov 9;5(5):e1100789. doi: 10.1080/2162402X.2015.1100789. PMID: 27467911; PMCID: PMC4910699.

FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
Holtick U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, Leitzke S, Burst A, Hallek M, von Bergwelt-Baildon M, Scheid C, Chemnitz JM.
Eur J Haematol. 2016 May;96(5):475-82. doi: 10.1111/ejh.12615. Epub 2015 Aug 25. PMID: 26132980.

OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.
Holtick U, Chemnitz JM, Shimabukuro-Vornhagen A, Theurich S, Chakupurakal G, Krause A, Fiedler A, Luznik L, Hellmich M, Wolf D, Hallek M, von Bergwelt-Baildon M, Scheid C. 
Eur J Haematol. 2016 Jan;96(1):27-35. doi: 10.1111/ejh.12541. Epub 2015 Mar 16. PMID: 25703164; PMCID: PMC4844370.

NK cells link obesity-induced adipose stress to inflammation and insulin resistance.
Wensveen FM, Jelenčić V, Valentić S, Šestan M, Wensveen TT, Theurich S, Glasner A, Mendrila D, Štimac D, Wunderlich FT, Brüning JC, Mandelboim O, Polić B.
Nat Immunol. 2015 Apr;16(4):376-85. doi: 10.1038/ni.3120. Epub 2015 Mar 2. PMID: 25729921.

Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis.
Holtick U, Albrecht M, Chemnitz JM, Theurich S, Shimabukuro-Vornhagen A, Skoetz N, Scheid C, von Bergwelt-Baildon M.
Crit Rev Oncol Hematol. 2015 May;94(2):179-88. doi:10.1016/j.critrevonc.2014.12.007. Epub 2014 Dec 18. PMID: 25604498.

top

2014

Multimerized form of recombinant human CD40 ligand supports long-term activation and proliferation of B cells.
Garcia-Marquez MA, Shimabukuro-Vornhagen A, Theurich S, Kochanek M, Weber T, Wennhold K, Dauben A, Dzionek A, Reinhard C, von Bergwelt-Baildon M. A
Cytotherapy. 2014 Nov;16(11):1537-1544. doi: 10.1016/j.jcyt.2014.05.011. PMID: 25287602.

Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma. 
Theurich S, Schlaak M, Steguweit H, Heukamp LC, Wennhold K, Kurschat P, Rabenhorst A, Hartmann K, Schlösser H, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Stadler R, von Bergwelt-Baildon M.
J Clin Oncol. 2016 Apr 20;34(12):e110-6. doi: 10.1200/JCO.2013.50.9471. Epub 2014 Oct 27. PMID: 25348001.

Inhibition of protein geranylgeranylation specifically interferes with CD40-dependent B cell activation, resulting in a reduced capacity to induce T cell immunity.
Shimabukuro-Vornhagen A, Zoghi S, Liebig TM, Wennhold K, Chemitz J, Draube A, Kochanek M, Blaschke F, Pallasch C, Holtick U, Scheid C, Theurich S, Hallek M, von Bergwelt-Baildon MS. 
J Immunol. 2014 Nov 15;193(10):5294-305. doi: 10.4049/jimmunol.1203436. Epub 2014 Oct 13. PMID:
25311809.

CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation.
Holtick U, Frenzel LP, Shimabukuro-Vornhagen A, Theurich S, Claasen J, Scheid C, von Bergwelt-Baildon M, Fröhlich H, Wendtner CM, Chemnitz JM.
Ann Hematol. 2015 Jan;94(1):129-37. doi: 10.1007/s00277-014-2166-1. Epub 2014 Aug 15. PMID: 25118994.

Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity.
Müller P, Martin K, Theurich S, von Bergwelt-Baildon M, Zippelius A. 
Oncoimmunology. 2014 Aug 3;3(8):e954460. doi: 10.4161/21624011.2014.954460. PMID: 25610745; PMCID: PMC4292760.

Characterization of tumor-associated B-cell subsets in patients with colorectal cancer.
Shimabukuro-Vornhagen A, Schlößer HA, Gryschok L, Malcher J, Wennhold K, Garcia-Marquez M, Herbold T, Neuhaus LS, Becker HJ, Fiedler A, Scherwitz P, Koslowsky T, Hake R, Stippel DL, Hölscher AH, Eidt S, Hallek M, Theurich S, von Bergwelt-Baildon MS.
Oncotarget. 2014 Jul 15;5(13):4651-64. doi: 10.18632/oncotarget.1701. PMID: 25026291; PMCID: PMC4148088.

Microtubule-depolymerizing agents used in antibody-drug conjugates induce antitumor immunity
by stimulation of dendritic cells.
Müller P, Martin K, Theurich S, Schreiner J, Savic S, Terszowski G, Lardinois D, Heinzelmann-Schwarz VA, Schlaak M, Kvasnicka HM, Spagnoli G, Dirnhofer S, Speiser DE, von Bergwelt-Baildon M, Zippelius A. 
Cancer Immunol Res. 2014 Aug;2(8):741-55. doi: 10.1158/2326-6066.CIR-13-0198. Epub 2014 Apr 21. PMID: 24916470.

Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M. Cochrane Database Syst Rev. 2014 Apr 20;(4):CD010189. doi: 10.1002/14651858.CD010189.pub2. PMID: 24748537.

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-
associated resistance to insulin.
Mauer J, Chaurasia B, Goldau J, Vogt MC, Ruud J, Nguyen KD, Theurich S, Hausen AC, Schmitz J, Brönneke HS, Estevez E, Allen TL, Mesaros A, Partridge L, Febbraio MA, Chawla A, Wunderlich FT, Brüning JC.
Nat Immunol. 2014 May;15(5):423-30. doi: 10.1038/ni.2865. Epub 2014 Mar 30. PMID: 24681566; PMCID: PMC4161471.

Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institution.
Chemnitz JM, Chakupurakal G, Bäßler M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Leitzke S, Von Bergwelt-Baildon MS, Scheid C.
ISRN Hematol. 2014 Mar 5;2014:853435. doi: 10.1155/2014/853435. PMID: 24729881; PMCID: PMC3963108.

Overcoming tumor-mediated immunosuppression. Schlößer HA, Theurich S, Shimabukuro-Vornhagen A, Holtick U, Stippel DL, von Bergwelt-Baildon M.
Immunotherapy. 2014;6(9):973-88. doi: 10.2217/imt.14.58. PMID: 25341119.

 

2013

Comment on "multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies".
Shimabukuro-Vornhagen A, Schlößer HA, Stippel DL, Theurich S, von Bergwelt-Baildon M.
J Immunol. 2013 Nov 1;191(9):4471. doi: 10.4049/jimmunol.1390052. PMID: 24141851.

Allogeneic stem cell transplantation in patients with aggressive primary cutaneous T-cell lymphoma - a case series of the ADF working group "cutaneous lymphomas".
Moritz RK, Ditschkowski M, Klemke CD, Terras S, Schlaak M, Knorr M, Theurich S, Hegenbart U, Kremens B, Beelen DW, Stücker M, Kreuter A; working group "cutaneous lymphomas" of the Arbeitsgemeinschaft für Dermatologische Forschung (ADF), Germany.
J Dtsch Dermatol Ges. 2014 Jan;12(1):39-46. doi: 10.1111/ddg.12212. Epub 2013 Oct 17. PMID: 24134607.

Vaccination with dendritic cell-tumor fusion cells in multiple myeloma patients: a promising strategy?
Garcia-Marquez MA, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon
M. Immunotherapy. 2013 Oct;5(10):1039-42. doi: 10.2217/imt.13.96. PMID: 24088074.

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.
Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P.
Cochrane Database Syst Rev. 2013 Aug 29;2013(8):CD008908. doi: 10.1002/14651858.CD008908.pub3. PMID: 23986525; PMCID: PMC7156921.

CD30-targeted therapy with brentuximab vedotin and DLI in a patient with T-cell posttransplantation
lymphoma: induction of clinical remission and cellular immunity.
Theurich S, Wennhold K, Wedemeyer I, Rothe A, Hübel K, Shimabukuro-Vornhagen A, Holtick U, Hallek M, Scheid C, von Bergwelt-Baildon M.
Transplantation. 2013 Aug 15;96(3):e16-8. doi: 10.1097/TP.0b013e31829a9258. PMID: 23917689.

18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to
brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Kahraman D, Theurich S, Rothe A, Kuhnert G, Sasse S, Scheid C, Dietlein M, Drzezga A, von Bergwelt-Baildon M, Kobe C.
Leuk Lymphoma. 2014 Apr;55(4):811-6. doi: 10.3109/10428194.2013.819575. Epub 2013 Jul 29. PMID: 23805904.

CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.
Wennhold K, Shimabukuro-Vornhagen A, Theurich S, von Bergwelt-Baildon M.
Expert Rev Vaccines. 2013 Jun;12(6):631-7. doi: 10.1586/erv.13.39. PMID: 23750793.

Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.
Theurich S, Fischmann H, Chakupurakal G, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Rothe A, Scheid C, Hallek M, Skoetz N, von Bergwelt-Baildon M.
Crit Rev Oncol Hematol. 2013 Oct;88(1):178-86. doi: 10.1016/j.critrevonc.2013.03.009. Epub 2013 Apr 2. PMID: 23561334.

Cyclin A1, a promising tumor antigen: the devil is in the amino acids.
Wennhold K, Theurich S, von Bergwelt-Baildon M.
Expert Rev Anticancer Ther. 2013 Mar;13(3):243-5. doi: 10.1586/era.12.175. PMID: 23477508.

The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect.
Shimabukuro-Vornhagen A, Liebig TM, Koslowsky T, Theurich S, von Bergwelt-Baildon MS. 
Cell Immunol. 2013 Jan;281(1):62-7. doi: 10.1016/j.cellimm.2013.01.001. Epub 2013 Jan 29. PMID: 23454682

top

2012

Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission.
Theurich S, Malcher J, Wennhold K, Shimabukuro-Vornhagen A, Chemnitz J, Holtick U, Krause A, Kobe C, Kahraman D, Engert A, Scheid C, Chakupurakal G, Hallek M, von Bergwelt-Baildon M.
J Clin Oncol. 2013 Feb 10;31(5):e59-63. doi: 10.1200/JCO.2012.43.6832. Epub 2012 Dec 26. PMID: 23269992.

Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
Weber T, Ocheni S, Binder M, Theurich S, Scheid C, Schmid C, Müller LP, Christopeit M, Bacher U.
Acta Haematol. 2013;129(3):135-6. doi: 10.1159/000343422. Epub 2012 Nov 29. PMID: 23207834.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.
Cochrane Database Syst Rev. 2012 Sep 12;(9):CD009159. doi: 10.1002/14651858.CD009159.pub2. PMID: 22972135.

Mast cells play a protumorigenic role in primary cutaneous lymphoma.
Rabenhorst A, Schlaak M, Heukamp LC, Förster A, Theurich S, von Bergwelt-Baildon M, Büttner R, Kurschat P, Mauch C, Roers A, Hartmann K.
Blood. 2012 Sep 6;120(10):2042-54. doi: 10.1182/blood-2012-03-415638. Epub 2012 Jul 26. PMID: 22837530.

Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.
Rothe A, Sasse S, Goergen H, Eichenauer DA, Lohri A, Jäger U, Bangard C, Böll B, von Bergwelt Baildon M, Theurich S, Borchmann P, Engert A. 
Blood. 2012 Aug 16;120(7):1470-2. doi: 10.1182/blood-2012-05-430918. Epub 2012 Jul 11. Erratum in: Blood. 2014 Aug 14;124(7):1201. PMID: 22786877.

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma.Schlaak M, Pickenhain J, Theurich S, Skoetz N, von Bergwelt-Baildon M, Kurschat P. 
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008908. doi: 10.1002/14651858.CD008908.pub2. Update in: Cochrane Database Syst Rev. 2013;8:CD008908. PMID: 22258991.

top

2011

Activated primary human B cells efficiently induce early CD40L and CD107a expression in CD4+ T cells.
Theurich S, Malcher J, Becker HJ, Chemnitz JM, Liebig TM, Shimabukuro-Vornhagen A, von Bergwelt-Baildon M.
Blood. 2011 Nov 24;118(22):5979-80. doi: 10.1182/blood-2011-05-356683. PMID: 22123910.

Intermediate intensity conditioning regimen containing FLAMSA, treosulfan, cyclophosphamide, and ATG
for allogeneic stem cell transplantation in elderly patients with relapsed or high-risk acute myeloid leukemia.
Chemnitz JM, von Lilienfeld-Toal M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Krause A, Brossart P, Hallek M, Scheid C. 
Ann Hematol. 2012 Jan;91(1):47-55. doi: 10.1007/s00277-011-1253-9. Epub 2011 May 17. PMID: 21584670.

top

2009 and before

Rituximab reduces the incidence of acute graft-versus-host disease.
Christopeit M, Schütte V, Theurich S, Weber T, Grothe W, Behre G. 
Blood. 2009 Mar 26;113(13):3130-1. doi: 10.1182/blood-2009-01-200527. PMID: 19324911.

Successful treatment of severe sinusoidal obstruction syndrome despite multiple organ failure with defibrotide after allogeneic stem cell transplantation: a case report.
Behre G, Theurich S, Christopeit M, Weber T.
J Med Case Rep. 2009 Mar 10;3:6164. doi: 10.4076/1752-1947-3-6164. PMID: 19830097; PMCID: PMC2726490.

Graft-versus-lymphoma effect in a 64-year-old caucasian woman after allogeneic stem-cell transplantation: a case report.
Behre G, Weber T, Theurich S, Christopeit M.
J Med Case Rep. 2009 Jan 13;3:10. doi: 10.1186/1752-1947-3-10. PMID: 19144104; PMCID: PMC2647932.

top

Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease.
Mueller LP, Theurich S, Christopeit M, Grothe W, Muetherig A, Weber T, Guenther S, Behre G.
Eur J Haematol. 2007 Jun;78(6):527-31. doi: 10.1111/j.1600-0609.2007.00851.x. PMID: 17509106.

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.
Stühmer T, Chatterjee M, Hildebrandt M, Herrmann P, Gollasch H, Gerecke C, Theurich S, Cigliano L, Manz RA, Daniel PT, Bommert K, Vassilev LT, Bargou RC.
Blood. 2005 Nov 15;106(10):3609-17. doi: 10.1182/blood-2005-04-1489. Epub 2005 Aug 4. PMID: 16081689.

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells.
Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Döhner K, Bommert K, Stein H, Dörken B. 
J Pathol. 2003 Nov;201(3):413-20. doi: 10.1002/path.1454. PMID: 14595753.

top